Posted by Michael Wonder on 11 Oct 2021
Paying for cancer drugs that prove their benefit
11 October 2021 - The United States pays prices for brand name drugs that are estimated to be 256% higher than other wealthy nations.
To restrain high prices for drugs that receive accelerated approval, we propose a new policy approach at the Center for Medicare and Medicaid Innovation (CMMI): pay for drugs that work.
